Norcliffe Capital led the latest investment as the cancer diagnostics firm reached its £3.5m target.
"Achieving the £3.5m target enables us to accelerate our plans. We will shortly complete our move into new lab and office facilities and increase staffing to 15, bringing forward key operational and commercial appointments."